=?utf-8?Q?Non=E2=80=93Small_Cell_Lung_Cancer:_5_Management_Challenges?=

SUBJECT:
PRI: NORMAL
FROM:
M
medscape_clinical_focus@mail.medscape.com
DATE:
2015-04-24 16:51:57
MSG_ID:
<63ac5749-8680-4d6f-8024-da9168789814@xtinp2mta402.xt.local>
RECIPIENTS:
TO:
R
rhb@rspdc.com
CONTENT: TEXT: YES | HTML: YES
PROCESSED
Medscape
http://click.mail.medscape.com/?qs=00c3c7f6cb90853f8b297d280b3c8cd7ba61c54e9a0a7b4327a84e93dae37e49d2d4dac779e3e671

Non-Small Cell Lung Cancer:
5 Management Challenges
Lung cancer is the leading cause of US cancer deaths, and non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Learn more about optimal workup and management of the three varieties of NSCLC: adenocarcinoma, squamous cell carcinoma (SCC), and large cell cancer.


http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cabc2a7d9a6661c95343c652b8e36fbf906dc7ba1de4da208cbf7fe14a4e49b6c
View now ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cabc2a7d9a6661c95343c652b8e36fbf906dc7ba1de4da208cbf7fe14a4e49b6c

Essential Resources

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c4eb3d6798b9147c435ac155531069a8a51b4dc0649324d094254b747828f13cc
Non-Small Cell Lung Cancer ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c6b4e75a57bd6dc99a1a2b27d88e33c9dfe6a733ce475160cdd1b47e66d22bdce
Non-Small Cell Lung Cancer Guidelines ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c8815eac6a3e2c2966d3613d9f8728fb01a1fa3ef5344e3b29dcdd10cbb1a1718
Non-Small Cell Lung Cancer Treatment Protocols ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c9b1b5c94d0d1d711f59d34cf7a714ba110b47cd96fab8c9562a4b409a499c7dc
Imaging in Non-Small Cell Lung Cancer ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c0ce61bc6c65ebf0ca390b4bbd914b60a7956bb228a44cd46431706cd683d906f

Recent Articles About NSCLC

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c29b38132091dddb1e68af48f60fb3558a9b9a17b58ff1485dce7e46d513bb0f7
2nd ESMO Consensus Conference in Lung Cancer: locally-advanced stage III NSCLC ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c1fbfd5f95e10752ed952b590a9efcf4e142c767a1f5cb6f6fb4dabf53a10c5a0
Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cbf1f88e8c17317ddb7965007a9a6ddf1a01f0c48f6e91e869b0abd2701659564
Recombinant mutated human TNF in combination with chemotherapy for stage IIIB/IV NSCLC ›

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c0f10b3ed65ed9cc29664535f855a63505d93b54c4ccfcc45c76ca3cd7a8c4562
Overall survival and long-term safety of nivolumab in patients with previously treated advanced NSCLC ›

Access the latest drug and disease information and point-of-care tools at

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c8153daa40554c4711793ac1d21ed3892f86493209a73ccce8728f47847c87792
reference.medscape.com ›


Follow us on:
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c694ef63a543ede9f165c2206055ab3d2b4ad5c0da1c13ffe190c4c4515ed349c


http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c694ef63a543ede9f165c2206055ab3d2b4ad5c0da1c13ffe190c4c4515ed349c


Twitter
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cf81331260d3dd4a632285dcb8e31d96a70b44b609fa7550ed259b562f10ed385


http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cf81331260d3dd4a632285dcb8e31d96a70b44b609fa7550ed259b562f10ed385


Facebook
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c57473712df67e2b91ca0b2b9c305148a9370ffbeb292916e3d0ec9e97a27839a

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c57473712df67e2b91ca0b2b9c305148a9370ffbeb292916e3d0ec9e97a27839a
YouTube
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c80147d53d99461d32ee146f86fe9d2529db858065dad98549f26d39a5af41cc8

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c80147d53d99461d32ee146f86fe9d2529db858065dad98549f26d39a5af41cc8
LinkedIn
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cfa8b030c99f1ed26135fcfe0daa92572d3118b39ee594245a8293745348bf8d5


http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cfa8b030c99f1ed26135fcfe0daa92572d3118b39ee594245a8293745348bf8d5


RSS


http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c1f210a99391ee73d04c79de558cf0ddf2d306883c93a0d9d963b1480f7c85143
Help |
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c329f050cc54417d2055b2e9ace687e8421865a1818986a2bab9b8349818cca38
Password Assistance |
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87cdc6d0901deb5a6d6409b4ad5ed5367aa23962735a1596adb7a1530e776348a53
My Account |
http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c346fdbf4f8697058975d42795144156ee42e711adb3319b8072699bdc89e50b1
Privacy Policy


You are receiving this communication because you are a registered member of Medscape.

The email address associated with your membership is
mailto:RHB@RSPDC.COM
RHB@RSPDC.COM .

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c6f049900a308237faf58610d1235927986aba2bfbc9c59798e7e7959d2888b4e
Unsubscribe from Medscape Clinical Focus

http://click.mail.medscape.com/?qs=c62fb54e5d6ba87c2d797b0e36460d6b158ba78b42fa9877a5a0c20e68ff178d1d9e4bcd461cbbeb
Unsubscribe from all Medscape from WebMD newsletters

Medscape from WebMD

825 Eighth Avenue

New York, NY 10019
METADATA:
THREAD:
INDEX: AdhhnkNBxS/2Cr0eQruCZG+RXjlybw==
EMAIL DETAILS
